P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
about
NPP4 is a procoagulant enzyme on the surface of vascular endotheliumBlood cells: an historical account of the roles of purinergic signallingG-protein-coupled receptors signaling pathways in new antiplatelet drug developmentMicroglial P2Y12 deficiency/inhibition protects against brain ischemiaPurinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host ResponseMolecular Basis of Purinergic Signal Metabolism by Ectonucleotide Pyrophosphatase/Phosphodiesterases 4 and 1 and Implications in StrokePlatelets are dispensable for antibody-mediated transfusion-related acute lung injury in the mouse.Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.ADP-induced bladder contractility is mediated by P2Y12 receptor and temporally regulated by ectonucleotidases and adenosine signaling.New aspects on efficient anticoagulation and antiplatelet strategies in sheep.Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y ReceptorsPlatelet Gi protein Gαi2 is an essential mediator of thrombo-inflammatory organ damage in mice.Pistacia chinensis Methanolic Extract Attenuated MAPK and Akt Phosphorylations in ADP Stimulated Rat Platelets In VitroPlatelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model.Platelet aggregation measurement for assessment of hemostasis failure mechanisms in patients with gastroduodenal ulcer bleeding.Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury.Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.Systems biology of platelet-vessel wall interactions.Antiplatelet drugs: which targets for which treatments?Platelet reactivity in sepsis syndrome: results from the PRESS study.Platelet-targeted pharmacologic treatments as anti-cancer therapy.Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridinesSepsis favors high-on-clopidogrel platelet reactivity.P2Y12 receptor inhibition augments cytotoxic effects of cisplatin in breast cancer.8-BuS-ATP derivatives as specific NTPDase1 inhibitors.A peripherally restricted P2Y12 receptor antagonist altered rat tumor incidences with no human relevance: Mode of action consistent with dopamine agonism.P2Y(12) receptor on the verge of a neuroinflammatory breakdownComparison of cytotoxic and anti-platelet activities of polyphenolic extracts from Arnica montana flowers and Juglans regia husks.P2Y12 Receptors in Tumorigenesis and Metastasis.Associations of P2Y12R gene polymorphisms with susceptibility to coronary heart disease and clinical efficacy of antiplatelet treatment with clopidogrel.Heterotrimeric G-protein subunit Gα contributes to agonist-sensitive apoptosis and degranulation in murine platelets
P2860
Q24299151-094F8FFD-AA4B-487C-AB33-E5F1B52EA469Q26799623-8AEC741F-0BAE-4BDD-833B-E481B5B8BA7AQ26864951-5811E6CA-18AB-4608-851D-389C4564D89AQ27309972-FF1C6F9A-1F99-4F4F-8F04-971B799FFAA1Q27314997-7121C847-F821-4957-A5E9-4DB674FBB58BQ27680880-8072073C-CAED-4A47-9305-5C9BB4C3B551Q33431384-70F80FA0-1CDF-4B0C-AB06-46F6762CC74DQ33624653-B7499E8B-312E-44E3-BB77-2879ED5B65BFQ34512888-4E0C079D-853F-486A-BCFD-46883EEAAC4BQ35006714-996EB305-9B7F-4A25-85C0-B984F8C83B25Q35130686-43CD37A9-CC30-41C4-85ED-2C198FD4FBC1Q35580301-675C48DD-D3D4-497C-8FDA-E7B33818AC39Q35644702-B7FB10AA-E93F-4B02-BF46-95E3B0C4020FQ36147916-075307CA-1E00-47EB-BB17-4686B054E138Q36330189-E516B737-AC8A-4573-BF1F-B55EDEC871FEQ37092257-1B1A19B5-9DE5-43F1-954A-CA7496E54C66Q37700810-B69E079F-C227-4ACD-B09B-90D3E24FE02AQ38151563-AEFF8024-E022-4B59-8459-B2115241EDDDQ38284002-65546696-E533-4FB4-82A8-BCCD6ECD52B2Q38543308-D89E0F65-EE30-4D36-B749-B6C481B98734Q38608797-31E3B2C6-CDBB-42CB-9FBA-B13FD37922B7Q38657846-04C94C74-0CEC-40EA-BC64-94445529BC56Q38694069-CFC4AC97-A5A1-4069-A76F-CE8EB920C432Q38716021-9425023C-0B8F-4D3A-BF3F-F4829010CEB4Q39169265-1B35FF09-F4B3-4F75-A1AE-2502B0CC396DQ39989919-DEDD61CE-0745-48C7-9E76-2E9D6BAB1FF9Q41680809-3719DFCE-C2FD-44AF-A2EA-90A7C4678728Q42077163-AB8435CF-3279-4930-845C-36B00ACC15E4Q48324589-2D26EB95-EA11-4C03-B81A-D4943DC7E354Q49884998-46496A22-0AE0-4517-9155-0F1314B5C2FDQ51547504-E485F321-C6A5-4ADE-823B-A5EE511BE493Q58763582-859CBC02-7C4F-4DD2-BA62-42411FA0E135
P2860
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
@ast
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
@en
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
@nl
type
label
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
@ast
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
@en
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
@nl
prefLabel
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
@ast
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
@en
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
@nl
P2860
P1476
P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells
@en
P2860
P2888
P304
P356
10.1007/S11302-012-9303-X
P407
P577
2012-09-01T00:00:00Z
P5875
P6179
1045470081